Skip to content
Living

Singapore to invest US$15 million on pharmacy industry

By Wei ZhangSingapore
2 min read
Pharmacy
Pharmacy
In this article (4)

Singapore has stated its interest to invest in the pharmacy industry worth US$15 million.

“Singapore will use the three-hour service facility system in arranging the permit of its plan to make investment in the pharmacy sector,” Chief of Investment Coordinating Board Franky Sibarani stated on a press release received here on Sunday.

Franky said the candidate investor company has a data centre operated in India with employment reached 12 thousand people in the world.

The company employs 600 researchers and markets their products to 18 European countries and also more than 30 others in the world. The investor is the first company who utilize nano technology for pharmacy industry.

“Its product is a medicine used to protect live cell from cancer and eliminate cancer,” Franky said.

According to Franky, the company is interested to invest in Indonesia because the country has big market, added with other ASEAN countries.

Indonesia, says Franky, need investment in pharmacy industry to boost technology transfer.

The Board noted that the company also is a also a challenge to Indonesia, particularly the related ministries, to provide service for permit in a short length of time.

“Thus, the coordinating board pushes the relevant agency to process permits in three hours as the investment will involved an amount of US$8 million,” Franky went on.

The coordinating agency has met several Singaporean companies engaged in telecommunication, pharmacy, real estate and maritime sectors.

During the meeting, the agency also signed a Memorandum of Understanding (MoU) with UOB Bank to promote investment potential.

Singapore is one of the biggest foreign direct investment source to Indonesia.

The country has noted Foreign Direct Investment up to the third quarter of 2015 at US$ 30 billion with 6,868 projects in the transportation, telecommunication, warehousing, plantation, mining, mineral and non-metal sectors as well as in the power generator sector.

Questions & Answers

Q.

What is the primary product of the investor company mentioned in the article?

A.

The investor company's product is a medicine that protects live cells from cancer and works to eliminate cancer. This product utilises nanotechnology, making it unique in the pharmacy industry.

Q.

Why is the investor company interested in investing in Indonesia?

A.

The company is interested due to Indonesia's large market, which is further supplemented by the wider ASEAN region. Indonesia also needs investment in pharmacy to boost technology transfer.

Q.

What challenge does this investment present to Indonesian ministries?

A.

The investment challenges Indonesian ministries to provide permits quickly, specifically within a three-hour timeframe. The coordinating board is pushing agencies to achieve this for investments of US$8 million.

Reader pulse

Is this a positive step for regional retail?

22,127 votes so far

Weekly Briefing

Asia's retail intelligence, in your inbox

Tuesday, Thursday and a Saturday Weekly Wrap: the retail stories, numbers and moves that mattered across Asia. Nothing else, and you can unsubscribe in one click.

  • Top industry moves and market shifts
  • Weekly data-driven analysis from across Asia
  • Tuesday, Thursday and the Saturday Weekly Wrap

Read by retail operators, investors and brand teams across Asia.

Protected by a quick human check. No spam, ever. Unsubscribe in one click.

SecureGDPR ready